Chronischer Husten

Chronischer Husten ist definiert als Husten, der länger als 8 Wochen anhält. Er ist ein Symptom praktisch aller pneumologischen Erkrankungen und sollte nach Abklärung der zugrunde liegenden Diagnose möglichst kausal behandelt werden. Nicht immer lässt sich jedoch eine zugrunde liegende Erkrankung diagnostizieren.

Abstract

Chronic cough (i.e., cough lasting >8 weeks) has a global prevalence of approximately 10%. The individual burden can be long-lasting, with some patients experiencing cough for many years. Although chronic cough is often a symptom of respiratory diseases (e.g., lung cancer, tuberculosis, chronic obstructive pulmonary disease) or associated with triggers (e.g., asthma, gastroesophageal reflux disease, rhinosinusitis) and may resolve after targeted treatment of these conditions, some patients continue to cough despite optimal treatment (refractory chronic cough, RCC) or have no identifiable conditions presumed to be contributing to the cough (unexplained chronic cough, UCC). In patients with chronic cough, it is critical to perform a thorough initial patient assessment with adherence to a diagnostic algorithm (e.g., of the German Respiratory Society Cough Guidelines) to identify the cause of the symptom cough and provide appropriate treatment; or diagnose RCC and UCC. Primary care physicians should provide the initial diagnostic workup of patients with chronic cough (history, physical exam, chest X-ray and spirometry). If no cause of the cough can be identified, referral to specialists (e.g., pulmonologists, gastroenterologists, otolaryngologists) may be appropriate. Increased appreciation of chronic cough as a distinct condition, rather than as only a symptom of other diseases, may help overcome current challenges in diagnosing and managing chronic cough.

Schlüsselwörter

Chronischer Husten - chronischer idiopathischer Husten - chronisch refraktärer Husten - Asthma - gastroösophagealer Reflux - Rhinosinusitis

Keywords

chronic cough - refractory chronic cough - unexplained chronic cough - asthma - gastrooesophageal reflux - rhinosinusitis

Publikationsverlauf

Artikel online veröffentlicht:
24. August 2023

• Literatur

• 1 Song WJ, Chang YS, Faruqi S. et al. The global epidemiology of chronic cough in adults: a systematic review and meta-analysis. Eur Respir J 2015; 45: 1479-1481
• 2 Kaplan AG. Chronic cough in adults: make the diagnosis and make a difference. Pulm Ther 2019; 5: 11-21
• 3 Schappert SM, Burt CW. Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 2001–02. Vital Health Stat 2006; 13: 1-66
• 4 Morice AH, Millqvist E, Bieksiene K. et al. ERS guidelines on the diagnosis and treatment of chronic cough in adults and children. Eur Respir J 2020; 55: 1901136
• 5 Kardos P, Dinh QT, Fuchs KH. et al. Leitlinie der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin zur Diagnostik und Therapie von erwachsenen Patienten mit Husten. Pneumologie 2019; 73: 143-180
• 6 Krueger K, Gehrke-Beck S, Holzinger F. et al. Akuter und chronischer Husten: S3-Leitlinie. AWMF-Register-Nr. 053-013. DEGAM-Leitlinie Nr. 11. AWMF 2021. https://www.awmf.org/uploads/tx_szleitlinien/053-013l_S3_akuter-und-chronischer-Husten_2021-06.pdf
• 7 Irwin RS, Corrao WM, Pratter MR. Chronic persistent cough in the adult: the spectrum and frequency of causes and successful outcome of specific therapy. Am Rev Respir Dis 1981; 123: 413-417
• 8 Shay S, Tutuian R, Sifrim D. et al. Twenty-four hour ambulatory simultaneous impedance and pH monitoring: a multicenter report of normal values from 60 healthy volunteers. Am J Gastroenterol 2004; 99: 1037-1043
• 9 Kahrilas PJ, Altman KW, Chang AB. et al. Chronic cough due to gastroesophageal reflux in adults: CHEST guideline and expert panel report. Chest 2016; 150: 1341-1360
• 10 Morice AH. Chronic cough hypersensitivity syndrome. Cough 2013; 9: 14
• 11 Kardos P, Gebhardt T. Chronisch persistierender Husten (CPH) in der Praxis: Diagnostik und Therapie bei 329 Patienten in 2 Jahren. Pneumologie 1996; 50: 437-441
• 12 Morice A, Kardos P. Comprehensive evidence-based review on European antitussives. BMJ Open Respir Res 2016; 3: e000137
• 13 Schaefer A, Kehr MS, Giannetti BM. et al. A randomized, controlled, double-blind, multi-center trial to evaluate the efficacy and safety of a liquid containing ivy leaves dry extract (EA 575) vs. placebo in the treatment of adults with acute cough. Pharmazie 2016; 71: 504-509
• 14 Fischer J, Dethlefsen U. Efficacy of cineole in patients suffering from acute bronchitis: a placebo-controlled double-blind trial. Cough 2013; 9: 25
• 15 Matthys H, de MC, Carls C. et al. Efficacy and tolerability of myrtol standardized in acute bronchitis. A multi-centre, randomised, double-blind, placebo-controlled parallel group clinical trial vs. cefuroxime and ambroxol. Arzneimittelforschung 2000; 50: 700-711
• 16 Gillissen A, Wittig T, Ehmen M. et al. A multi-centre, randomised, double-blind, placebo-controlled clinical trial on the efficacy and tolerability of GeloMyrtol(R) forte in acute bronchitis. Drug Res (Stuttg) 2013; 63: 19-27
• 17 Timmer A, Gunther J, Motschall E. et al. Pelargonium sidoides extract for treating acute respiratory tract infections 5. Cochrane Database Syst Rev 2013; 10: CD006323
• 18 Matthys H, Lizogub VG, Malek FA. et al. Efficacy and tolerability of EPs 7630 tablets in patients with acute bronchitis: a randomised, double-blind, placebo-controlled dose-finding study with a herbal drug preparation from Pelargonium sidoides. Curr Med Res Opin 2010; 26: 1413-1422
• 19 Kemmerich B, Eberhardt R, Stammer H. Efficacy and tolerability of a fluid extract combination of thyme herb and ivy leaves and matched placebo in adults suffering from acute bronchitis with productive cough. A prospective, double-blind, placebo-controlled clinical trial. Arzneimittelforschung 2006; 56: 652-660
• 20 Kemmerich B. Evaluation of efficacy and tolerability of a fixed combination of dry extracts of thyme herb and primrose root in adults suffering from acute bronchitis with productive cough. A prospective, double-blind, placebo-controlled multicentre clinical trial. Arzneimittelforschung 2007; 57: 607-615